Sign in

CIK 0001672619

  • Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811523849
Phone
+1 650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,585,364
in 5 filings, $979K under 10b5-1 plans

Net −$1,585,364. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-02 Conner Edward R. Director Grant or award · Stock Options (Right to Buy) +8,500 8,500
2021-06-29 Conner Edward R. Director Grant or award · Stock Options (Right to Buy) +7,728 7,728
2020-04-22 Conner Edward R. Director Grant or award · Stock Option (right to buy) +15,457 15,457

Page 1 of 1 · 3 trades